Sign inGet started

Tester Jason E.

Insider CIK 1827272 · TARS Director, 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TARS Tarsus Pharmaceuticals, In A Award deriv2021-06-152021-06-1710,000— $010,000SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2021-06-152021-06-1710,000— $010,000SEC↗
TARS Tarsus Pharmaceuticals, In C Conversion deriv2020-10-202020-10-2021,575— $00SEC↗
TARS Tarsus Pharmaceuticals, In C Conversion deriv2020-10-202020-10-201,434,790— $00SEC↗
TARS Tarsus Pharmaceuticals, In C Conversion deriv2020-10-202020-10-2071,427— $00SEC↗
TARS Tarsus Pharmaceuticals, In C Conversion deriv2020-10-202020-10-20245,966— $00SEC↗
TARS Tarsus Pharmaceuticals, In C Conversion deriv2020-10-202020-10-203,698— $00SEC↗
TARS Tarsus Pharmaceuticals, In C Conversion2020-10-202020-10-2071,427— $01,752,183SEC↗
TARS Tarsus Pharmaceuticals, In P Buy2020-10-202020-10-20168,750$16.00 $2.70M1,920,933SEC↗
TARS Tarsus Pharmaceuticals, In C Conversion2020-10-202020-10-20245,966— $01,680,756SEC↗
TARS Tarsus Pharmaceuticals, In C Conversion2020-10-202020-10-201,434,790— $01,434,790SEC↗
TARS Tarsus Pharmaceuticals, In P Buy2020-10-202020-10-203,125$16.00 $50.0K28,398SEC↗
TARS Tarsus Pharmaceuticals, In C Conversion2020-10-202020-10-203,698— $025,273SEC↗
TARS Tarsus Pharmaceuticals, In C Conversion2020-10-202020-10-2021,575— $021,575SEC↗